Augmented Virtual Reality for Reducing Pain, Stress, Anxiety and Improve Self Efficacy in Adult C… (NCT07152938) | Clinical Trial Compass
CompletedNot Applicable
Augmented Virtual Reality for Reducing Pain, Stress, Anxiety and Improve Self Efficacy in Adult Cancer Patients Undergoing Chemotherapy in The West Bank
The main purpose of this study is to examine the effect of using AVR on pain, stress, anxiety, and SE among adult cancer patients undergoing chemotherapy in the West Bank hospitals in Palestine. The main questions it aims to answer are:
1. What is the effect of AVR therapy on pain levels score compared with routine care during chemotherapy session among cancer patients?
2. What is the effect of AVR therapy on the stress levels compared with routine care during chemotherapy session among cancer patients?
3. What is the effect of AVR therapy on the anxiety compared with routine care during chemotherapy session among cancer patients?
4. What is the effect of AVR therapy on the general SE compared with routine care during chemotherapy session among cancer patients?
The participants divided into two groups, the intervention group, which receives AVR, and the control group, which receives standard treatment. The study used a pretest and posttest design to assess the effect of AVR on the study variables (pain, stress, anxiety and self-efficacy).
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Adult patients aged 18-60 years undergoing chemotherapy for breast or colon cancer.
. Stage I or II cancer, as defined by the study protocol.
. Manageable levels of pain, anxiety, and stress, appropriate for participation in the intervention.
Exclusion criteria
. Age over 60 years.
. Cancer types other than breast or colon cancer.
. Severe pain, anxiety, or stress that could interfere with participation or require intensive care beyond the study scope.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in pain intensity during chemotherapy
Timeframe: Immediately before chemotherapy and immediately after the session (June 2023 - September 2023).